Friday, April 24, 2020

Breast Cancer Summit 2020

Breast Cancer Treatment

The mainstays of breast cancer treatment are surgeryradiationchemotherapyhormone therapy, and targeted therapy. But scientists continue to study novel treatments and drugs, along with new combinations of existing treatments.

It is now known that breast cancer can be divided into subtypes that respond differently to various types of treatment. The three main clinical subtypes of breast cancer are:
  • Hormone receptor (HR) positive. HR-positive breast cancers are those that contain the estrogen receptor (ER) and/or progesterone receptor (PR). These cancers grow in response to these hormones and can be treated with hormone therapies.
  • Human epidermal growth factor receptor 2 (HER2) positive. HER2-positive breast cancers are those that have high amounts of the HER2 protein; they can be HR positive or HR negative. These cancers can be treated with therapies that target HER2.
  • Triple-negative breast cancer. Such cancers do not contain ER, PR, or HER2.
Contact us: breastcancer@globalconferences.net

No comments:

Post a Comment